These data suggest that eIF4E represents a logical therapeutic target to increase tumor cell radiosensitivity and overcome cancer radioresistance that may support potential clinical value of eIF4E-targeting strategies for oral cancer treatment. Here, EIF4E is linked to neoplasm.